Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via contacting:
HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2
Tel: 01 676 4971
Fax: 01 676 2517
Side effects should also be reported to Sanofi: Tel: 01 403 5600 e-mail: IEPharmacovigilance@sanofi.com